Intuitive Surgical (ISRG) News Today

Intuitive Surgical, Inc. (NASDAQ:ISRG) shares have moved lower today following a flurry of analyst downgrades and insider selling, despite some bulls highlighting the company’s long-term growth prospects.

• Bank of America Securities reiterated its Buy rating, arguing that Intuitive’s growth potential outweighs reprocessing risks.
• Several commentators still view ISRG as a “premier high-growth” name and an attractive long-term holding opportunity.
• Zacks reports note strong retail interest and overall bullish Wall Street sentiment, but without major rating shifts.
• Inclusion of ISRG exposure in AI-focused ETF recommendations provides indirect positive outlook for tech-oriented investors.
• Deutsche Bank became the first on Wall Street to issue a Sell rating, cutting its price target to $440 from $515 (–15.8%).
• Multiple firms have since downgraded ISRG and trimmed price targets, citing rising competition and valuation concerns.
• Shares plunged over 5% intraday and closed down nearly 6.8% on June 9 after downgrade headlines and insider stock sales.
• Profit-taking and heightened competition worries have added further downward pressure on the stock today.